checkAd

     224  0 Kommentare Merck Announces Final Results of Any and All Tender Offers

    Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today the final results of the previously announced offers to purchase (collectively, the “Offers”) any and all of the outstanding notes listed in the table below (collectively, the “Notes”). On Nov. 6, 2017, Merck commenced the Offers in accordance with the terms and conditions set forth in the Offer to Purchase, dated Nov. 6, 2017 (the “Offer to Purchase”). The Offers expired at 5:00 p.m., New York City time, on Nov. 13, 2017 (the “Expiration Time”).

    The total principal amount of Notes tendered and accepted for purchase pursuant to the Offers was approximately $584.7 million, exclusive of Notes tendered pursuant to the Guaranteed Delivery Procedures (as defined in the Offer to Purchase). The aggregate Total Consideration (as defined in the Offer to Purchase), excluding accrued and unpaid interest, to be paid in respect of all Notes accepted for purchase pursuant to the Offers will be approximately $800.0 million.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Merck & Co!
    Long
    116,66€
    Basispreis
    0,88
    Ask
    × 12,04
    Hebel
    Short
    133,67€
    Basispreis
    0,89
    Ask
    × 11,71
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Lesen Sie auch

    Merck was advised by the tender agent and information agent for the Offers that, as of the Expiration Time, the aggregate principal amount of each series of Notes specified in the table below was validly tendered and not withdrawn at or prior to the Expiration Time.

     
    Title of Notes      

    CUSIP
    Number

         

    Principal
    Amount
    Outstanding

         

    Principal
    Amount
    Tendered and Accepted

         

    Aggregate Total
    Consideration(1)

    6.55% Senior Notes due 2037       806605AH4       $524,052,000       $156,353,000       $226,431,978
    5.85% Notes due 2039 589331AQ0 $418,907,000 $146,509,000 $199,262,496
    6.50% Senior Notes due 2033 806605AG6 $717,611,000 $65,917,000 $91,836,883
    5.95% Debentures due 2028 589331AE7 $357,745,000 $49,463,000 $63,865,636
    5.75% Notes due 2036 589331AM9 $372,130,000 $31,323,000 $41,726,308
    6.40% Debentures due 2028 589331AD9 $326,507,000 $75,724,000 $99,898,887
    6.30% Debentures due 2026 589331AC1 $153,077,000 $18,015,000 $22,558,923
    5.76% Notes due 2037 58933NAL3 $79,132,000 $41,401,000 $54,397,188

    ______________________

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Merck Announces Final Results of Any and All Tender Offers Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today the final results of the previously announced offers to purchase (collectively, the “Offers”) any and all of the outstanding notes listed …

    Schreibe Deinen Kommentar

    Disclaimer